Annual Cash & Cash Equivalents
$4.87B$1.73B-26.23%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.87B, down -26.23% on
- Historical Performance
- GSK annual cash & cash equivalents is down -17.00% over the past 3 years, and down -23.14% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -56.53% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 98.05% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.87B | -26.2% | -17.0% | -23.1% | -56.5% | |
| Quarterly Cash & Cash Equivalents | $4.45B | +3.3% | -44.3% | -21.1% | -57.6% | |
| Price | $47.77 | +42.9% | +35.0% | +23.2% | +26.4% | |
| Annual Current Assets | $21.29B | -10.4% | -15.8% | -17.6% | -25.0% | |
| Annual Total Liabilities | $58.08B | -1.4% | -25.8% | -28.5% | +12.0% | |
| Annual Working Capital | -$5.89B | -90.5% | +13.0% | +2.5% | -166.9% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -48.6% |
| 5Y | $9.48B | -48.6% | |
| All | $11.21B | -56.5% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.87B | at low | |
| 5Y | $4.87B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of GSK?
As of today, GSK annual cash & cash equivalents is $4.87B
What is 1-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -26.23% year-over-year
What is 3-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -17.00% over the past 3 years
How far is GSK annual cash & cash equivalents from its all-time high?
GSK annual cash & cash equivalents is currently -56.53% below its historical high of $11.21B set on December 31, 2009
How does GSK annual cash & cash equivalents rank versus sector peers?
GSK annual cash & cash equivalents is higher than 98.05% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly Cash & Cash Equivalents
$4.45B$508.59M-10.26%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $4.45B, down -10.26% on
- Historical Performance
- GSK quarterly cash & cash equivalents is up +3.30% year-over-year, and down -44.32% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -71.35% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +18.03% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 97.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.45B | -10.3% | +3.3% | -44.3% | -21.1% | |
| Annual Cash & Cash Equivalents | $4.87B | – | -26.2% | -17.0% | -23.1% | |
| Price | $47.77 | +8.3% | +42.9% | +35.0% | +23.2% | |
| Quarterly Current Assets | $24.02B | -0.8% | +3.5% | +6.3% | -6.5% | |
| Quarterly Total Liabilities | $61.37B | -0.3% | +2.6% | +6.5% | -21.3% | |
| Quarterly Working Capital | -$4.70B | -26.8% | +15.8% | -498.2% | -58.2% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.79B | -23.1% | |
| 3Y | $9.48B | N/A | -53.0% |
| 5Y | $10.37B | -57.1% | |
| All | $15.54B | -71.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.45B | at low | |
| 3Y | $3.77B | +18.0% | |
| 5Y | $3.77B | +18.0% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GSK?
As of today, GSK quarterly cash & cash equivalents is $4.45B
What is GSK quarterly cash & cash equivalents most recent change?
GSK quarterly cash & cash equivalents was down -10.26% on September 1, 2025
What is 1-year change in GSK quarterly cash & cash equivalents?
GSK quarterly cash & cash equivalents is up +3.30% year-over-year
How far is GSK quarterly cash & cash equivalents from its all-time high?
GSK quarterly cash & cash equivalents is currently -71.35% below its historical high of $15.54B set on March 31, 2015
How does GSK quarterly cash & cash equivalents rank versus sector peers?
GSK quarterly cash & cash equivalents is higher than 97.69% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk